目的观察经皮给药辅助治疗小儿支气管肺炎的疗效。方法将确诊为支气管肺炎患儿312例分为经皮给药治疗组(212例)和对照组(100例),比较其疗效。结果治疗组患儿临床症状及体征消失时间显著短于对照组(P<0.01),治疗组治愈率、总有效率均明显高于对照组(P<0.01)。结论中药经皮给药辅助治疗小儿肺炎具有安全、方便、无痛苦、疗效显著等优点,为小儿肺炎的治疗开辟了新途径。 Objective To observe the efficacy of percutaneous administration of bronchial pneumonia in children. Methods 312 children diagnosed as bronchial pneumonia were divided into transdermal drug treatment group (212 cases) and control group (100 cases), and their efficacy was compared. Results The clinical symptoms and signs disappeared in the treatment group were significantly shorter than those in the control group (P <0.01). The cure rate and total effective rate in the treatment group were significantly higher than those in the control group (P <0.01). Conclusion The transdermal drug-assisted adjuvant treatment of pediatric pneumonia is safe, convenient, painless and has obvious curative effect. It opens up a new way for the treatment of pediatric pneumonia.